NEWEST CLINICAL APPROACHES WITH PACLITAXEL (TAXOL) - INTRODUCTION

被引：0
|
作者：
PINEDO, HM
机构：
来源：
SEMINARS IN ONCOLOGY | 1994年 / 21卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] Extravasation of paclitaxel (TAXOL®) -: Clinical course
    Riedel, U
    Serke, M
    Schönfeld, N
    Loddenkemper, R
    [J]. ONKOLOGIE, 1999, 22 (04): : 318 - 320
  • [2] CLINICAL TOXICITIES ENCOUNTERED WITH PACLITAXEL (TAXOL(R))
    ROWINSKY, EK
    EISENHAUER, EA
    CHAUDHRY, V
    ARBUCK, SG
    DONEHOWER, RC
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 1 - 15
  • [3] THE CLINICAL-PHARMACOLOGY OF PACLITAXEL (TAXOL(R))
    ROWINSKY, EK
    DONEHOWER, RC
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (04) : 16 - 25
  • [4] PACLITAXEL (TAXOL)
    KOHLER, DR
    GOLDSPIEL, BR
    [J]. PHARMACOTHERAPY, 1994, 14 (01): : 3 - 34
  • [5] EXTRAVASATION OF PACLITAXEL (TAXOL(R))
    RAYMOND, E
    CARTIER, S
    CANUEL, C
    LOUVET, C
    DEMUYNCK, B
    DEBRAY, M
    VARETTE, C
    BAUX, S
    MIMOUN, M
    DEGRAMONT, A
    KRULIK, M
    [J]. REVUE DE MEDECINE INTERNE, 1995, 16 (02): : 141 - 142
  • [6] Discovery of more efficacious analogs of paclitaxel (TAXOL) for human clinical evaluation.
    Kadow, JF
    Chen, SH
    Dextraze, P
    Fairchild, CR
    Golik, J
    Hansel, SB
    Johnston, KA
    Kramer, RA
    Lee, FY
    Long, BH
    Ouellet, C
    Perrone, RK
    Rose, WC
    Schulze, GE
    Xue, M
    Wei, JN
    Wittman, MD
    Wong, H
    Wright, JJK
    Zoeckler, ME
    Vyas, DM
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U55 - U55
  • [7] THE NEWEST WHITNEY INTRODUCTION
    Pollock, Lindsay
    [J]. ART IN AMERICA, 2015, 103 (05): : 101 - 101
  • [8] Comparative in vitro properties and clinical pharmacokinetics of paclitaxel following the administration of Taxol® and Paxene®
    Scripture, CD
    Szeheni, J
    Loos, WJ
    Figg, WD
    Sparreboom, A
    [J]. CANCER BIOLOGY & THERAPY, 2005, 4 (05) : 555 - 560
  • [9] Cytotoxicity of fractionated paclitaxel (Taxol®) administration in vitroZytotoxizität fraktionierter Paclitaxel-(Taxol®-)Gabe in vitro
    L. Plasswilm
    N. Cordes
    R. Fietkau
    R. Sauer
    [J]. Strahlentherapie und Onkologie, 1998, 174 : 37 - 42
  • [10] Paclitaxel (Taxol(R)): A review of its antitumor activity in clinical studies - Minireview
    Hajek, R
    Vorlicek, J
    Slavik, M
    [J]. NEOPLASMA, 1996, 43 (03) : 141 - 154
12345